HTFL Stock: Price, Earnings History and SEC Filings
Heartflow, Inc. (HTFL) last traded at $59.05, down 2.45% on the latest session and up 18.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.16 against an analyst estimate of $-0.22, a beat of 27.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
HTFL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $-0.16 | $-0.22 | +27.27% |
| Mar 2026 | May 14, 2026 | $-0.23 | $-0.24 | +4.17% |
| Dec 2025 | Mar 18, 2026 | $-0.18 | $-0.24 | +25.00% |
| Sep 2025 | Nov 12, 2025 | $-0.35 | $-0.27 | -29.63% |
HTFL beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How HTFL reacts to earnings
Across its last 5 earnings releases, HTFL moved 13.3% on average the next session, in either direction. It rose after 2 of 5 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-13 | After close | +35.70% |
| 2026-05-14 | After close | -12.17% |
| 2026-03-18 | After close | +1.65% |
| 2025-11-12 | After close | -13.43% |
| 2025-09-10 | Before open | -3.52% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
HTFL financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $176M | -$117M | -$59M | -66.3% | $-3.17 |
| 2024 | $126M | -$96M | -$73M | -76.6% | $-17.98 |
| 2023 | $87M | -$96M | -$83M | -109.7% | $-25.32 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for HTFL
- 10-Q · Aug 13, 2026
- 8-K · Aug 13, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 18, 2026Shareholder vote
- 10-Q · May 14, 2026
- 8-K · May 14, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 29, 2026
- 10-K · Mar 18, 2026
- 8-K · Mar 18, 2026Results of operations, Financial statements and exhibits
- 8-K · Jan 12, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Nov 12, 2025
Insider filing activity
HTFL insiders filed 17 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
HTFL news
- TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of PatientsNov 1, 2026 · finance.yahoo.com
- Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI PushOct 29, 2026 · finance.yahoo.com
- Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue EstimatesOct 27, 2026 · finance.yahoo.com
- 3 AI Stocks To Own In October 2026Oct 25, 2026 · finance.yahoo.com
- Pfizer And 2 Other AI Healthcare Stocks To WatchOct 24, 2026 · finance.yahoo.com
- Elucid Statement on Heartflow Lawsuit: Reaffirms Mission, Confidence in Its Technology, and Commitment to Patients and PhysiciansOct 23, 2026 · finance.yahoo.com
- Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026Oct 19, 2026 · finance.yahoo.com
About Heartflow, Inc.
Heartflow, Inc. (HTFL) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.